Log In
BCIQ
Print this Print this
 

PF-562271

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionFAK/Pyk2 tyrosine kinase inhibitor
Molecular Target Focal adhesion kinase (FAK)
Mechanism of ActionFocal adhesion kinase (FAK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today